Clinical Trials Directory

Trials / Unknown

UnknownNCT05480176

The China National COPD Screening Program

The National Chronic Obstructive Pulmonary Disease Screening Program in China

Status
Unknown
Phase
Study type
Observational
Enrollment
800,000 (estimated)
Sponsor
China-Japan Friendship Hospital · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The national COPD screening program is in a cross-sectional manner at the baseline, planning to recruit a total of 800,000 participants from 160 districts or counties (5,000 for each site on average) from 31 provinces, autonomous regions or municipalities directly under the central government of China. The filtered COPD high-risk population and confirmed COPD patients will be managed and followed up according to the standardized clinical guidelines. The major aims of the program are to estimate the prevalences of COPD high-risk population and under- or miss- diagnosed COPD patients, and to manage the development and outcomes of the disease.

Conditions

Interventions

TypeNameDescription
OTHERComprehensive intervention and management ⅠMainly health advisory.
OTHERComprehensive intervention and management ⅡHealth advisory and regular follow-ups.
OTHERComprehensive intervention and management ⅢPharmaceutical and non-pharmaceutical (e.g. health advisory, rehabilitation, etc.) interventions according to standardized clinical guidelines, with regular follow-ups.

Timeline

Start date
2021-10-09
Primary completion
2022-12-31
Completion
2025-12-31
First posted
2022-07-29
Last updated
2022-07-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05480176. Inclusion in this directory is not an endorsement.